Rifaximin in treatment of acute bacterial diarrhea: A randomized, single-blind and multicenter clinical trial

Object: To evaluate the efficacy and safety of rifaximin against acute bacterial diarrhea. Methods: The effect of rifaximin for the treatment of acute bacterial diarrhea was investigated in a multi-center randomized, single-blind and clinical trial with control of ciprofloxacin. Patients were administered with rifaximin 0.4g tid on the first day, followed by 0. 4g bid; as for ciprofloxacin 0.25g tid on the first day, followed by 0.25g bid, …